US Stock MarketDetailed Quotes

IOVA Iovance Biotherapeutics

Watchlist
  • 7.830
  • -0.130-1.63%
Close Dec 13 16:00 ET
  • 8.030
  • +0.200+2.55%
Post 20:01 ET
2.39BMarket Cap-5.29P/E (TTM)

Iovance Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
29.86%-58.97M
-4.77%-98.43M
-22.51%-122.28M
-23.59%-361.82M
-8.11%-83.97M
-32.10%-84.08M
-21.02%-93.95M
-35.25%-99.82M
-28.44%-292.76M
-44.24%-77.67M
Net income from continuing operations
26.56%-83.54M
8.85%-97.1M
-5.22%-112.98M
-12.16%-444.04M
-10.50%-116.38M
-14.20%-113.76M
-7.23%-106.53M
-17.21%-107.37M
-15.67%-395.89M
-6.03%-105.32M
Operating gains losses
-126.05%-93K
--10K
---96K
--70K
---106K
--357K
----
----
----
----
Depreciation and amortization
12.89%11.15M
38.55%10.86M
73.90%9.91M
56.74%33.13M
70.21%9.71M
89.83%9.88M
49.41%7.84M
14.44%5.7M
51.18%21.14M
27.84%5.71M
Deferred tax
-22.37%-1.52M
-205.66%-1.46M
---1.41M
---3.48M
---1.76M
---1.24M
---477K
--0
--0
--0
Change In working capital
-326.10%-13.32M
-237.50%-38.71M
-153.71%-32.55M
-125.48%-6.52M
295.87%11.89M
-45.73%5.89M
-77.66%-11.47M
-24.64%-12.83M
-111.78%-2.89M
-85.75%3M
-Change in receivables
-73,324.24%-24.16M
-94,960.61%-31.37M
---83K
---149K
---149K
--33K
---33K
--0
--0
----
-Change in inventory
-3,171.47%-10.87M
7.23%-8.86M
---6.74M
---10.12M
---923K
--354K
---9.55M
--0
--0
--0
-Change in prepaid assets
-214.92%-2.47M
92.55%-211K
239.16%5.89M
-372.39%-10.06M
-280.89%-5.15M
192.92%2.15M
-368.88%-2.83M
-13.89%-4.23M
-176.76%-2.13M
26.04%2.85M
-Change in payables and accrued expense
340.18%27.14M
21.44%4.42M
-378.19%-28.83M
1,984.92%24.6M
744.95%20.83M
-55.02%6.17M
147.11%3.64M
17.05%-6.03M
-95.73%1.18M
-87.24%2.47M
-Change in other current liabilities
-4.69%-2.95M
0.11%-2.69M
-8.56%-2.79M
-455.82%-10.79M
-17.85%-2.72M
-424.81%-2.81M
-1,369.81%-2.69M
-472.32%-2.57M
66.98%-1.94M
-368.15%-2.31M
Cash from discontinued investing activities
Operating cash flow
29.86%-58.97M
-4.77%-98.43M
-22.51%-122.28M
-23.59%-361.82M
-8.11%-83.97M
-32.10%-84.08M
-21.02%-93.95M
-35.25%-99.82M
-28.44%-292.76M
-44.24%-77.67M
Investing cash flow
Cash flow from continuing investing activities
38.24%-48.8M
125.65%40.22M
-172.69%-111.51M
-160.53%-155.24M
-15,901.52%-72.85M
-207.19%-79.01M
-263.72%-156.78M
77.30%153.4M
194,184.09%256.46M
-99.34%461K
Net PPE purchase and sale
36.04%-2.29M
95.36%-442K
26.36%-4.17M
-9.13%-22.29M
-16.78%-3.53M
-157.89%-3.58M
-108.04%-9.52M
50.49%-5.66M
45.64%-20.43M
60.07%-3.02M
Net business purchase and sale
--0
--0
---52.57M
---212.63M
--253K
---3.38M
---209.51M
--0
--0
--0
Net investment purchase and sale
35.45%-46.51M
-34.68%40.66M
-134.43%-54.76M
-71.22%79.68M
-2,097.39%-69.57M
-195.95%-72.06M
-37.96%62.25M
62.38%159.06M
634.31%276.88M
-95.47%3.48M
Cash from discontinued investing activities
Investing cash flow
38.24%-48.8M
125.65%40.22M
-172.69%-111.51M
-160.53%-155.24M
-15,901.52%-72.85M
-207.19%-79.01M
-263.72%-156.78M
77.30%153.4M
194,184.09%256.46M
-99.34%461K
Financing cash flow
Cash flow from continuing financing activities
-79.31%41.95M
14,809.76%152.83M
-25.02%193.58M
143.47%462.96M
-99.50%962K
90,033.33%202.8M
149.59%1.03M
18,119.62%258.17M
-20.53%190.15M
4,492.17%190.58M
Net issuance payments of debt
----
----
----
--0
----
----
----
----
--0
----
Net common stock issuance
-76.61%47.52M
--151.87M
-23.91%197.91M
144.47%463.28M
-100.00%1K
--203.18M
--0
--260.1M
-6.72%189.5M
--189.5M
Proceeds from stock option exercised by employees
--713K
47.21%1.95M
--364K
-24.99%2.47M
6.90%1.15M
--0
127.84%1.33M
--0
-90.61%3.3M
-74.14%1.07M
Net other financing activities
-1,556.20%-6.28M
-232.23%-1M
-143.70%-4.7M
-5.51%-2.8M
---186K
---379K
---301K
---1.93M
---2.65M
--0
Cash from discontinued financing activities
Financing cash flow
-79.31%41.95M
14,809.76%152.83M
-25.02%193.58M
143.47%462.96M
-99.50%962K
90,033.33%202.8M
149.59%1.03M
18,119.62%258.17M
-20.53%190.15M
4,492.17%190.58M
Net cash flow
Beginning cash position
-20.69%235.11M
-74.43%140.62M
-23.87%181.32M
182.47%238.16M
167.76%334.15M
158.89%296.44M
458.61%549.91M
182.47%238.16M
15.73%84.31M
92.96%124.8M
Current changes in cash
-265.78%-65.82M
137.89%94.62M
-112.90%-40.21M
-135.17%-54.1M
-237.48%-155.85M
285.80%39.7M
-1,654.74%-249.71M
2,106.16%311.75M
1,242.60%153.85M
477.24%113.37M
Effect of exchange rate changes
162.87%1.25M
96.68%-125K
---491K
---2.74M
--3.02M
---1.99M
---3.77M
--0
----
----
End cash Position
-48.96%170.54M
-20.69%235.11M
-74.43%140.62M
-23.87%181.32M
-23.87%181.32M
167.76%334.15M
158.89%296.44M
458.61%549.91M
182.47%238.16M
182.47%238.16M
Free cash flow
30.12%-61.26M
4.45%-98.87M
-19.88%-126.45M
-22.65%-384.11M
-8.43%-87.5M
-34.79%-87.66M
-25.86%-103.47M
-23.74%-105.48M
-17.95%-313.18M
-31.39%-80.69M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 29.86%-58.97M-4.77%-98.43M-22.51%-122.28M-23.59%-361.82M-8.11%-83.97M-32.10%-84.08M-21.02%-93.95M-35.25%-99.82M-28.44%-292.76M-44.24%-77.67M
Net income from continuing operations 26.56%-83.54M8.85%-97.1M-5.22%-112.98M-12.16%-444.04M-10.50%-116.38M-14.20%-113.76M-7.23%-106.53M-17.21%-107.37M-15.67%-395.89M-6.03%-105.32M
Operating gains losses -126.05%-93K--10K---96K--70K---106K--357K----------------
Depreciation and amortization 12.89%11.15M38.55%10.86M73.90%9.91M56.74%33.13M70.21%9.71M89.83%9.88M49.41%7.84M14.44%5.7M51.18%21.14M27.84%5.71M
Deferred tax -22.37%-1.52M-205.66%-1.46M---1.41M---3.48M---1.76M---1.24M---477K--0--0--0
Change In working capital -326.10%-13.32M-237.50%-38.71M-153.71%-32.55M-125.48%-6.52M295.87%11.89M-45.73%5.89M-77.66%-11.47M-24.64%-12.83M-111.78%-2.89M-85.75%3M
-Change in receivables -73,324.24%-24.16M-94,960.61%-31.37M---83K---149K---149K--33K---33K--0--0----
-Change in inventory -3,171.47%-10.87M7.23%-8.86M---6.74M---10.12M---923K--354K---9.55M--0--0--0
-Change in prepaid assets -214.92%-2.47M92.55%-211K239.16%5.89M-372.39%-10.06M-280.89%-5.15M192.92%2.15M-368.88%-2.83M-13.89%-4.23M-176.76%-2.13M26.04%2.85M
-Change in payables and accrued expense 340.18%27.14M21.44%4.42M-378.19%-28.83M1,984.92%24.6M744.95%20.83M-55.02%6.17M147.11%3.64M17.05%-6.03M-95.73%1.18M-87.24%2.47M
-Change in other current liabilities -4.69%-2.95M0.11%-2.69M-8.56%-2.79M-455.82%-10.79M-17.85%-2.72M-424.81%-2.81M-1,369.81%-2.69M-472.32%-2.57M66.98%-1.94M-368.15%-2.31M
Cash from discontinued investing activities
Operating cash flow 29.86%-58.97M-4.77%-98.43M-22.51%-122.28M-23.59%-361.82M-8.11%-83.97M-32.10%-84.08M-21.02%-93.95M-35.25%-99.82M-28.44%-292.76M-44.24%-77.67M
Investing cash flow
Cash flow from continuing investing activities 38.24%-48.8M125.65%40.22M-172.69%-111.51M-160.53%-155.24M-15,901.52%-72.85M-207.19%-79.01M-263.72%-156.78M77.30%153.4M194,184.09%256.46M-99.34%461K
Net PPE purchase and sale 36.04%-2.29M95.36%-442K26.36%-4.17M-9.13%-22.29M-16.78%-3.53M-157.89%-3.58M-108.04%-9.52M50.49%-5.66M45.64%-20.43M60.07%-3.02M
Net business purchase and sale --0--0---52.57M---212.63M--253K---3.38M---209.51M--0--0--0
Net investment purchase and sale 35.45%-46.51M-34.68%40.66M-134.43%-54.76M-71.22%79.68M-2,097.39%-69.57M-195.95%-72.06M-37.96%62.25M62.38%159.06M634.31%276.88M-95.47%3.48M
Cash from discontinued investing activities
Investing cash flow 38.24%-48.8M125.65%40.22M-172.69%-111.51M-160.53%-155.24M-15,901.52%-72.85M-207.19%-79.01M-263.72%-156.78M77.30%153.4M194,184.09%256.46M-99.34%461K
Financing cash flow
Cash flow from continuing financing activities -79.31%41.95M14,809.76%152.83M-25.02%193.58M143.47%462.96M-99.50%962K90,033.33%202.8M149.59%1.03M18,119.62%258.17M-20.53%190.15M4,492.17%190.58M
Net issuance payments of debt --------------0------------------0----
Net common stock issuance -76.61%47.52M--151.87M-23.91%197.91M144.47%463.28M-100.00%1K--203.18M--0--260.1M-6.72%189.5M--189.5M
Proceeds from stock option exercised by employees --713K47.21%1.95M--364K-24.99%2.47M6.90%1.15M--0127.84%1.33M--0-90.61%3.3M-74.14%1.07M
Net other financing activities -1,556.20%-6.28M-232.23%-1M-143.70%-4.7M-5.51%-2.8M---186K---379K---301K---1.93M---2.65M--0
Cash from discontinued financing activities
Financing cash flow -79.31%41.95M14,809.76%152.83M-25.02%193.58M143.47%462.96M-99.50%962K90,033.33%202.8M149.59%1.03M18,119.62%258.17M-20.53%190.15M4,492.17%190.58M
Net cash flow
Beginning cash position -20.69%235.11M-74.43%140.62M-23.87%181.32M182.47%238.16M167.76%334.15M158.89%296.44M458.61%549.91M182.47%238.16M15.73%84.31M92.96%124.8M
Current changes in cash -265.78%-65.82M137.89%94.62M-112.90%-40.21M-135.17%-54.1M-237.48%-155.85M285.80%39.7M-1,654.74%-249.71M2,106.16%311.75M1,242.60%153.85M477.24%113.37M
Effect of exchange rate changes 162.87%1.25M96.68%-125K---491K---2.74M--3.02M---1.99M---3.77M--0--------
End cash Position -48.96%170.54M-20.69%235.11M-74.43%140.62M-23.87%181.32M-23.87%181.32M167.76%334.15M158.89%296.44M458.61%549.91M182.47%238.16M182.47%238.16M
Free cash flow 30.12%-61.26M4.45%-98.87M-19.88%-126.45M-22.65%-384.11M-8.43%-87.5M-34.79%-87.66M-25.86%-103.47M-23.74%-105.48M-17.95%-313.18M-31.39%-80.69M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data